BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 31383312)

  • 1. Immunoproteomic analysis of Lawsonia intracellularis identifies candidate neutralizing antibody targets for use in subunit vaccine development.
    Obradovic M; Pasternak JA; Hon Ng S; Allan B; Brownlie R; Wilson HL
    Vet Microbiol; 2019 Aug; 235():270-279. PubMed ID: 31383312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of immunogenicity and protection mediated by Lawsonia intracellularis subunit vaccines.
    Fourie KR; Choudhary P; Ng SH; Obradovic M; Brownlie R; Anand SK; Wilson HL
    Vet Immunol Immunopathol; 2021 Jul; 237():110256. PubMed ID: 33971523
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multi-antigenic recombinant subunit vaccine against Lawsonia intracellularis: The etiological agent of porcine proliferative enteropathy.
    Montesino R; Gutiérrez N; Camacho F; Farnós O; Andrades S; González A; Acosta J; Cortez-San Martín M; Sánchez O; Ruiz A; Toledo JR
    Vaccine; 2019 Feb; 37(10):1340-1349. PubMed ID: 30711318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteomic analysis of Lawsonia intracellularis reveals expression of outer membrane proteins during infection.
    Watson E; Alberdi MP; Inglis NF; Lainson A; Porter ME; Manson E; Imrie L; Mclean K; Smith DGE
    Vet Microbiol; 2014 Dec; 174(3-4):448-455. PubMed ID: 25457368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of the route of administration on the mucosal and systemic immune responses to Lawsonia intracellularis vaccine in pigs.
    Nogueira MG; Collins AM; Dunlop RH; Emery D
    Aust Vet J; 2015 Apr; 93(4):124-6. PubMed ID: 25817978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaccination of pigs with attenuated Lawsonia intracellularis induced acute phase protein responses and primed cell-mediated immunity without reduction in bacterial shedding after challenge.
    Riber U; Heegaard PM; Cordes H; Ståhl M; Jensen TK; Jungersen G
    Vaccine; 2015 Jan; 33(1):156-62. PubMed ID: 25444804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An attenuated
    Park S; Won G; Lee JH
    J Vet Sci; 2019 May; 20(3):e24. PubMed ID: 31161742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel inactivated vaccine against Lawsonia intracellularis induces rapid induction of humoral immunity, reduction of bacterial shedding and provides robust gut barrier function.
    Roerink F; Morgan CL; Knetter SM; Passat MH; Archibald AL; Ait-Ali T; Strait EL
    Vaccine; 2018 Mar; 36(11):1500-1508. PubMed ID: 29336925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of a novel inactivated Lawsonia intracellularis vaccine in pigs against experimental infection and under field conditions.
    Jacobs AAC; Harks F; Hazenberg L; Hoeijmakers MJH; Nell T; Pel S; Segers RPAM
    Vaccine; 2019 Apr; 37(15):2149-2157. PubMed ID: 30867100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of protective immunity in pigs following oral administration of an avirulent live vaccine of Lawsonia intracellularis.
    Kroll JJ; Roof MB; McOrist S
    Am J Vet Res; 2004 May; 65(5):559-65. PubMed ID: 15141873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunological responses to vaccination following experimental Lawsonia intracellularis virulent challenge in pigs.
    Nogueira MG; Collins AM; Donahoo M; Emery D
    Vet Microbiol; 2013 May; 164(1-2):131-8. PubMed ID: 23478250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Field evaluation of an oral attenuated Lawsonia intracellularis vaccine for porcine proliferative enteropathy (ileitis).
    McOrist S; Smits RJ
    Vet Rec; 2007 Jul; 161(1):26-8. PubMed ID: 17617542
    [No Abstract]   [Full Text] [Related]  

  • 13. Potent O-antigen-deficient (rough) mutants of Salmonella Typhimurium secreting Lawsonia intracellularis antigens enhance immunogenicity and provide single-immunization protection against proliferative enteropathy and salmonellosis in a murine model.
    Park S; Won G; Kim J; Kim HB; Lee JH
    Vet Res; 2018 Jul; 49(1):57. PubMed ID: 29976253
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of an avirulent live vaccine against Lawsonia intracellularis in the prevention of proliferative enteropathy in experimentally infected weanling foals.
    Pusterla N; Vannucci FA; Mapes SM; Nogradi N; Collier JR; Hill JA; Difrancesco M; White AM; Akana NK; Simonek G; Gebhart CJ
    Am J Vet Res; 2012 May; 73(5):741-6. PubMed ID: 22533409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of Lawsonia intracellularis putative hemolysin protein A and characterization of its immunoreactivity.
    Kim J; Won G; Park S; Lee JH
    Vet Microbiol; 2017 Jun; 205():57-61. PubMed ID: 28622862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development, characterization and diagnostic application of a monoclonal antibody specific for a proteinase K resistant Lawsonia intracellularis antigen.
    Boesen HT; Jensen TK; Jungersen G; Riber U; Boye M; Møller K
    Vet Microbiol; 2005 Feb; 105(3-4):199-206. PubMed ID: 15708816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Salmonella delivered Lawsonia intracellularis novel epitope-fusion vaccines enhance immunogenicity and confers protection against Lawsonia intracellularis in mice.
    Park S; Kirthika P; Jawalagatti V; Senevirathne A; Lee JH
    Vet Microbiol; 2021 Dec; 263():109264. PubMed ID: 34710766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of a live attenuated vaccine against Lawsonia intracellularis in weaned and finishing pig settings in Finland.
    Peiponen KS; Tirkkonen BT; Junnila JJT; Heinonen ML
    Acta Vet Scand; 2018 Mar; 60(1):18. PubMed ID: 29566718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of immune efficacy of Omp2 protein against Lawsonia intracellularis in mice.
    Li M; Xiao N; Li J; Lin H; Fan H
    Vet Microbiol; 2021 Dec; 263():109274. PubMed ID: 34781192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel Lawsonia intracellularis autotransporter protein is a prominent antigen.
    Watson E; Clark EM; Alberdi MP; Inglis NF; Porter M; Imrie L; McLean K; Manson E; Lainson A; Smith DG
    Clin Vaccine Immunol; 2011 Aug; 18(8):1282-7. PubMed ID: 21697340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.